[ad_1]
Verona Pharma’s stock soars toward a record after $10 billion buyout deal with Merck.
[ad_2]
Source link
Merck dives into COPD treatments with $10 billion purchase of Verona Pharma
By Daniel snow
By Daniel snow
By Daniel snow
[ad_1]
Verona Pharma’s stock soars toward a record after $10 billion buyout deal with Merck.
[ad_2]
Source link
